We Doctor
Total Raised
$1.936BInvestors Count
17Deal Terms
3Investments
4Funding, Valuation & Revenue
10 Fundings
We Doctor has raised $1.936B over 10 rounds.
We Doctor's latest funding round was a Series G for $150M on July 5, 2022.
We Doctor's valuation in February 2021 was $7,000M.
We Doctor's latest post-money valuation is from February 2021.
Sign up for a free demo to see We Doctor's valuations in May 2018 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/5/2022 | Series G | $150M | 3 | |||
2/25/2021 | Series F - II | $400M | HongShan, Millennium Management, and Undisclosed Investors | $7,000M | 1 | |
12/17/2020 | Series F | $350M | Undisclosed Investors | 5 | ||
10/12/2020 | Series E | |||||
5/9/2018 | Series D |
Date | 7/5/2022 | 2/25/2021 | 12/17/2020 | 10/12/2020 | 5/9/2018 |
|---|---|---|---|---|---|
Round | Series G | Series F - II | Series F | Series E | Series D |
Amount | $150M | $400M | $350M | ||
Investors | HongShan, Millennium Management, and Undisclosed Investors | Undisclosed Investors | |||
Valuation | $7,000M | ||||
Revenue | |||||
Sources | 3 | 1 | 5 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
We Doctor Deal Terms
3 Deal Terms
We Doctor's deal structure is available for 3 funding rounds, including their Series F - II from February 25, 2021.
Round | Series F - II | Series D | Series C |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series F - II | |||||||||||||||
Series D | |||||||||||||||
Series C |
We Doctor Investors
17 Investors
We Doctor has 17 investors. Shandong Guotou invested in We Doctor's Series G funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/5/2022 | 7/5/2022 | 1 Series G | Private Equity | China | ||
3/18/2006 | 2/25/2021 | 3 Seed VC, Series C (2015), Series F - II (2021) | Venture Capital | China | ||
2/25/2021 | 2/25/2021 | 1 Series F - II | Asset/Investment Management | New York | ||
Asset/Investment Management | Bahrain | |||||
Venture Capital | China |
First funding | 7/5/2022 | 3/18/2006 | 2/25/2021 | ||
|---|---|---|---|---|---|
Last Funding | 7/5/2022 | 2/25/2021 | 2/25/2021 | ||
Investor | |||||
Rounds | 1 Series G | 3 Seed VC, Series C (2015), Series F - II (2021) | 1 Series F - II | ||
Board Seats | |||||
Type | Private Equity | Venture Capital | Asset/Investment Management | Asset/Investment Management | Venture Capital |
Location | China | China | New York | Bahrain | China |
We Doctor Acquisitions
2 Acquisitions
We Doctor acquired 2 companies. Their latest acquisition was Genea on August 31, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/31/2018 | Acq - Fin | 2 | ||||
1/30/2015 |
Date | 8/31/2018 | 1/30/2015 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources | 2 |
We Doctor Investments
4 Investments
We Doctor has made 4 investments. Their latest investment was in OrthoGuard as part of their Series A - II on December 27, 2021.
We Doctor Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/27/2021 | Series A - II | OrthoGuard | Yes | 5 | ||
8/3/2018 | Corporate Minority | |||||
11/13/2017 | Series A | |||||
10/28/2016 | Corporate Minority |
Date | 12/27/2021 | 8/3/2018 | 11/13/2017 | 10/28/2016 |
|---|---|---|---|---|
Round | Series A - II | Corporate Minority | Series A | Corporate Minority |
Company | OrthoGuard | |||
Amount | ||||
New? | Yes | |||
Co-Investors | ||||
Sources | 5 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare We Doctor to Competitors
Alodokter focuses on providing medical services through an integrated mobile solution. The company offers a platform for patient-doctor interactions, online booking of doctors and hospitals, and a comprehensive medical content database. Alodokter primarily serves the healthcare sector by connecting patients with healthcare providers and facilitating access to medical information. It was founded in 2014 and is based in Jakarta, Indonesia.
DokterSehat is a health-focused company operating in the healthcare and information services industry. The company provides reliable health-related articles, information on diseases, drugs, hospitals, doctors, pregnancy, sexuality, and more, all reviewed by a competent medical team. DokterSehat primarily serves the healthcare industry. It was founded in 2015 and is based in Jakarta, Indonesia.
Lemonilo is a company focused on making a healthy lifestyle accessible through its range of consumer packaged goods in the LOHAS and wellness sector. The company offers a variety of health-oriented products that are affordable, practical, and free from over 100 potentially harmful ingredients. Lemonilo primarily serves the health-conscious consumer market, with products available both online and in over 20,000 physical stores. Lemonilo was formerly known as Konsula. It was founded in 2016 and is based in Jakarta, Indonesia.
Good Doctor is a health-tech company. It focuses on the healthcare industry. The company offers a platform that connects healthcare professionals with patients, providing accessible health services without time and geographic constraints. Its services include health consultations via chat, online medicine purchases, and access to the latest health information. The company was founded in 2018 and is based in South Jakarta, Indonesia.
HonestDocs is a digital health platform focused on providing health information and services. The company offers a comprehensive resource for health care information, disease treatment guidance, and facilitates booking appointments with medical professionals. HonestDocs primarily serves individuals seeking medical knowledge and healthcare services. It was founded in 2019 and is based in Bangkok, Thailand.
Practo is an integrated healthcare company focusing on making healthcare accessible and affordable in the healthcare sector. The company offers services such as online doctor consultations, healthcare appointment bookings, and delivery of medicines. Practo also provides software solutions for healthcare providers to digitize and enhance the quality of care. It was founded in 2008 and is based in Bengaluru, India.
Loading...